KINSETIQ Trademark

Trademark Overview

On Friday, December 7, 2007, a trademark application was filed for KINSETIQ with the United States Patent and Trademark Office. The USPTO has given the KINSETIQ trademark a serial number of 77346985. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 7, 2011. This trademark is owned by Synta Pharmaceuticals Corp.. The KINSETIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of oncologic and inflammatory diseases
kinsetiq

General Information

Serial Number77346985
Word MarkKINSETIQ
Filing DateFriday, December 7, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 7, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 14, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of oncologic and inflammatory diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 12, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSynta Pharmaceuticals Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameSynta Pharmaceuticals Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Monday, February 7, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 7, 2011ABANDONMENT - NO USE STATEMENT FILED
Friday, June 18, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 17, 2010EXTENSION 3 GRANTED
Tuesday, June 15, 2010EXTENSION 3 FILED
Tuesday, June 15, 2010TEAS EXTENSION RECEIVED
Tuesday, February 9, 2010EXTENSION 2 GRANTED
Wednesday, January 6, 2010EXTENSION 2 FILED
Tuesday, February 9, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 6, 2010TEAS EXTENSION RECEIVED
Monday, July 6, 2009EXTENSION 1 GRANTED
Monday, July 6, 2009EXTENSION 1 FILED
Monday, July 6, 2009TEAS EXTENSION RECEIVED
Tuesday, January 6, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 14, 2008PUBLISHED FOR OPPOSITION
Wednesday, September 24, 2008NOTICE OF PUBLICATION
Monday, September 8, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 8, 2008ASSIGNED TO LIE
Thursday, August 28, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 27, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 27, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 27, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 28, 2008NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, March 28, 2008PRIORITY ACTION E-MAILED
Friday, March 28, 2008PRIORITY ACTION WRITTEN
Wednesday, March 26, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 17, 2008ASSIGNED TO EXAMINER
Wednesday, December 12, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

kinsetiq inflammatory diseases oncologic treatment preparations pharmaceutical